Drug Database
Back to search

Iceland· IS-IS/1/02/030/01

Elidel

A pimecrolimus product containing pimecrolimusum inn, registered in Iceland by Viatris ApS. The same ATC class is registered in 13 of our 19 countries.

ATC D11AH02

Checked against Icelandic Medicines Agency (Iceland) on

Informational only — not a medical device.

SOURCE REGISTER · ISIcelandic Medicines Agency (Iceland)normalisedElidelATCD11AH02REGISTER NO.IS-IS/1/02/030/01PACKS LISTED1CHECKEDSeptember 29, 2026
Compare price across countriesPer daily dose · free accountAsk the assistant about pimecrolimusum innAnswers with sources · free accountCheck interactionsSeverity free · mechanism on Growth

Where it is registered

Pimecrolimus is registered in 13 of 19 countries.

Countries holding a registration under ATC D11AH02 (pimecrolimus), each read from that country’s own register.

  • This record: Iceland, from Icelandic Medicines Agency (Iceland)
  • 8 of them publish a price we can compare per daily dose
Search pimecrolimus products by name

Pimecrolimus · ATC D11AH02

13 / 19 countries

  • Belgiumprice
  • Canada
  • Czechiaprice
  • Denmark
  • Finlandprice
  • Germany
  • Icelandprice
  • Netherlands
  • Norwayprice
  • Polandprice
  • Switzerlandprice
  • United Kingdom
  • United Statesprice
Blue: a registration under this ATC code. The ringed marker is this record’s country. Markets marked price publish a price we can compare per daily dose.

The record

At a glance

Icelandic Medicines Agency (Iceland)
Active substance
Pimecrolimusum INN
Manufacturer
Viatris ApS
Country
Iceland (IS)
ATC code
D11AH02
ATC class
Pimecrolimus
Defined daily dose
20 mg, T
Reimbursed
Not published by this register
Source register
Icelandic Medicines Agency (Iceland)
Last checked
September 29, 2026

Packs & prices · 1

1 priced
  • ean
    187595
    30 g x1 túpa
    ISK 6620

Regulatory notes

No shortage, Orange Book or US label notes for this record.

Interactions

217 interactions on record for pimecrolimus.

Graded by severity as the source publishes them — 9 moderate. Severity grades are free for everyone; mechanism and management come with Growth.

  • Severity for every pair — free, no plan needed
  • The source, licence and sync date on every record
  • Mechanism and what to do for each pair — Growth plan
Check pimecrolimus against other medicinesHow interaction checks work

Pimecrolimus · interactions on record

217 records

  • 9 moderate
  • 83 minor
  • 125 info

Most severe, free to view

  • FostamatinibB02BX09moderate
  • EchinaceaD03AH02moderate
  • TemsirolimusL01EG01moderate
  • SirolimusL01EG04moderate
  • Interaction severity from DDInter 2.0 (Xiong G. et al., Nucleic Acids Res.), licensed CC BY-NC 4.0 — free for non-commercial use only; not covered by the Drug Database commercial licence.
Mechanism and what to do, in the interaction check
Source: DDInter 2.0 · synced 29 Sept 2026. Grades as the source publishes them.

Same medicine, other countries

Pimecrolimus in 13 other countries

What each register calls a product with the same active substance — salts and hydrates count as the same.

All pimecrolimus products

Authorised across Europe · EMA

The same active substance is authorised in 27 EEA countries. Names it is sold under:

  • Austria · Elidel
  • Belgium · Elidel
  • Bulgaria · Елидел
  • Cyprus · Elidel
  • Czechia · Elidel
  • Germany · Elidel
  • Denmark · Elidel
  • Estonia · Elidel
  • Spain · Elidel
  • Finland · Elidel
  • United Kingdom (Northern Ireland) · Elidel
  • Greece · Elidel
  • Croatia · Elidel
  • Hungary · Elidel
  • Italy · Elidel
  • Lithuania · Elidel
  • Luxembourg · Elidel
  • Latvia · Elidel
  • Malta · Elidel
  • Netherlands · Elidel
  • Norway · Elidel
  • Poland · Elidel
  • Portugal · Elidel
  • Romania · Elidel
  • Sweden · Elidel
  • Slovenia · Elidel
  • Slovakia · Elidel

Source: European Medicines Agency, Article 57 product data.

Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of Icelandic Medicines Agency (Iceland). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.

For developers

The same record over the API, and the raw payload
GET /v1/drugs/f7573da1-0261-4ff9-b42d-2345c2a8f5fc
GET /v1/drugs/f7573da1-0261-4ff9-b42d-2345c2a8f5fc?format=fhir

Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.

{
  "form": "Krem",
  "source": "lyfjastofnun",
  "atc_raw": "D11AH02",
  "marketed": true,
  "strength": "10 mg/g",
  "ma_number": "IS/1/02/030/01",
  "substance": "Pimecrolimusum INN",
  "other_info": null,
  "legal_status": "(R) Lyfseðilsskylt",
  "ma_issued_serial": "37503"
}
API referenceMCP serverPlans

See everything about pimecrolimus.

This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.

Try it freeOpen in the console